Product Description
please call me ,to know more
AI Product Description
*The following content is generated by AI and is for reference only.
Pseudoginsenoside F11 is a distinctive saponin compound isolated primarily from the roots of *Panax notoginseng*, a plant renowned in traditional Asian medicine for its potent therapeutic properties. Chemically, this bioactive molecule belongs to the dammarane-type triterpenoid glycosides family, characterized by a complex steroid-like core structure attached to various sugar moieties. Its molecular formula is C36H62O8, and it is identified by the CAS registry number 107495-68-3. The specific arrangement of hydroxyl groups and glycosidic linkages distinguishes Pseudoginsenoside F11 from other ginsenosides, granting it unique physicochemical and biological behaviors essential for pharmaceutical applications.
The primary utility of Pseudoginsenoside F11 lies in its significant pharmacological potential, particularly regarding cardiovascular health and neuroprotection. Extensive research indicates that this compound exhibits strong antioxidant activity, effectively scavenging free radicals and reducing oxidative stress within biological systems. This mechanism is crucial for mitigating tissue damage associated with ischemia-reperfusion injuries, such as those occurring during heart attacks or strokes. Furthermore, studies suggest that Pseudoginsenoside F11 may improve microcirculation and inhibit platelet aggregation, thereby supporting vascular function and preventing thrombosis. These attributes position it as a promising candidate for developing novel treatments for hypertension and cerebral ischemia.
In the context of modern drug development, Pseudoginsenoside F11 serves as a valuable reference standard and active ingredient in functional food supplements and nutraceuticals. It is increasingly utilized in formulations aimed at enhancing immune response, reducing fatigue, and promoting overall vitality. Researchers continue to investigate its potential anti-inflammatory effects and its ability to modulate metabolic pathways related to diabetes and lipid disorders. As interest in natural products grows, the isolation and purification of high-purity Pseudoginsenoside F11 remain critical for validating its safety profile and efficacy in clinical settings. While further large-scale human trials are necessary to fully establish dosage guidelines, current evidence underscores its importance as a key bioactive component derived from medicinal herbs, bridging traditional wisdom with contemporary scientific innovation.